国泰中证沪港深创新药产业ETF(517110)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/12/31 |
330,099,000 |
492,099,000 |
186,000,000 |
24,000,000 |
162,000,000 |
49.08% |
2024/9/30 |
313,099,000 |
330,099,000 |
23,000,000 |
6,000,000 |
17,000,000 |
5.43% |
2024/6/30 |
291,099,000 |
313,099,000 |
62,000,000 |
40,000,000 |
22,000,000 |
7.56% |
2024/6/30 |
321,099,000 |
313,099,000 |
18,000,000 |
26,000,000 |
-8,000,000 |
-2.49% |
2024/3/31 |
291,099,000 |
321,099,000 |
44,000,000 |
14,000,000 |
30,000,000 |
10.31% |
2023/12/31 |
206,099,000 |
291,099,000 |
138,000,000 |
53,000,000 |
85,000,000 |
41.24% |
2023/12/31 |
265,099,000 |
291,099,000 |
40,000,000 |
14,000,000 |
26,000,000 |
9.81% |
2023/9/30 |
271,099,000 |
265,099,000 |
8,000,000 |
14,000,000 |
-6,000,000 |
-2.21% |
2023/6/30 |
206,099,000 |
271,099,000 |
90,000,000 |
25,000,000 |
65,000,000 |
31.54% |
2023/6/30 |
217,099,000 |
271,099,000 |
59,000,000 |
5,000,000 |
54,000,000 |
24.87% |
2023/3/31 |
206,099,000 |
217,099,000 |
31,000,000 |
20,000,000 |
11,000,000 |
5.34% |
2022/12/31 |
207,099,000 |
206,099,000 |
89,000,000 |
90,000,000 |
-1,000,000 |
-0.48% |
2022/12/31 |
242,099,000 |
206,099,000 |
1,000,000 |
37,000,000 |
-36,000,000 |
-14.87% |
2022/9/30 |
227,099,000 |
242,099,000 |
16,000,000 |
1,000,000 |
15,000,000 |
6.61% |
2022/6/30 |
207,099,000 |
227,099,000 |
72,000,000 |
52,000,000 |
20,000,000 |
9.66% |
2022/6/30 |
218,099,000 |
227,099,000 |
51,000,000 |
42,000,000 |
9,000,000 |
4.13% |
2022/3/31 |
207,099,000 |
218,099,000 |
21,000,000 |
10,000,000 |
11,000,000 |
5.31% |
2021/12/31 |
246,099,000 |
207,099,000 |
35,000,000 |
74,000,000 |
-39,000,000 |
-15.85% |
2021/12/31 |
246,099,000 |
207,099,000 |
35,000,000 |
74,000,000 |
-39,000,000 |
-15.85% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。